Saxenda (liraglutide) is a GLP-1 receptor agonist licensed for weight management in adults with obesity or overweight with related conditions The medication has no established direct effect on sex hormone regulation or the reproductive system Weight loss itself can influence menstrual patterns and potentially cause changes in bleeding, independent of medication Any unexplained vaginal bleeding requires medical assessment to exclude pregnancy, infection, structural abnormalities, or other underlying causes Postmenopausal bleeding or persistent intermenstrual bleeding warrants urgent referral according to NICE guidance Table of Contents Understanding Saxenda and Potential Side Effects Saxenda (liraglutide 3.0 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related health conditions such as type 2 diabetes, hypertension, or dyslipidaemia
Together with serum cobalamin concentration, it can also be useful to monitor serum MMA levels, since MMA reflects the actual bioavailability of the vitamin
B12 injection therapy might offer relief
Two common questions about B12 and hair include: Can vitamin B12 help with hair loss
Early mitochondrial and antioxidant support, followed by deeper detoxification and cellular resilience reinforcement with consistent use
The transdermal composition of claim 2 which sustains constant plasma levels of GHK-Cu or copper tripeptide in an animal from at least 48 hrs - 72 hrs after application
